U.S. Personal Products Stock News

If you are wondering whether BlackRock's current share price lines up with its underlying worth, you are not alone. Many investors are asking the same question right now. The stock last closed at US$951.17, with a 7 day return of a 9.3% decline, a 30 day return of an 11.9% decline, a year to date return of a 12.3% decline, but a 1 year return of 6.7%, a 3 year return of 61.6%, and a 5 year return of 47.2%. Recent attention on BlackRock has centered on how large asset managers are positioned...

Waters Corporation recently launched the ARES-G3 Rheometer within its TA Instruments line, a next-generation system that significantly increases data capture speed and cuts standard rheology test times through integrated Fast Frequency Chirps in upgraded TRIOS software. By enabling many tests without user calibration, maintaining compatibility with existing ARES-G2 methods and fixtures, and accelerating workflows that can save laboratories hundreds of workdays per year, the ARES-G3 Rheometer...

FedEx stock after recent performance data FedEx (FDX) shares have seen mixed short term moves, with a small daily gain, a decline over the past week, and a modest slip over the past month, while longer term returns remain positive. For investors, these return patterns sit alongside annual revenue of US$90.1b and net income of US$4.3b. Both revenue and net income show positive annual growth based on the latest figures provided. See our latest analysis for FedEx. The recent pullback in FedEx’s...

First Industrial Realty Trust (FR) is under fresh scrutiny after activist investor Land & Buildings escalated its governance campaign, challenging long-serving directors, urging board refreshment, and pushing for potential asset sales or even a full company sale. See our latest analysis for First Industrial Realty Trust. The activist campaign has landed as First Industrial’s share price trades at US$61.05, with a 30 day share price return of 2.40% and a year to date share price return of...

In early March 2026, Rocket Lab completed two successful missions within six days from launch sites in New Zealand and Virginia, while also unveiling silicon-based space solar arrays and reporting full-year 2025 revenue of US$601.8 million alongside a net loss of US$198.21 million. Together with a new multi-launch agreement with BlackSky and expanding hypersonic test services, these developments highlight Rocket Lab’s push toward a more integrated space infrastructure and power platform,...

Why Molson Coors Beverage (TAP) Is Back on Investors’ Radar Molson Coors Beverage (TAP) has attracted fresh attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year. See our latest analysis for Molson Coors Beverage. At a share price of $44.97, Molson Coors Beverage has seen momentum fade recently, with weaker short term share price returns contributing to a 1 year total shareholder return decline of...

McEwen Inc. recently experienced a setback when the TSX Venture Exchange refused to extend the expiry of 2,590,673 Goliath Resources warrants, which carried a US$2.50 exercise price and expired on March 10, 2026 under TSXV Policy 5.3. This decision removes a potential source of additional exposure to Goliath for McEwen and its investors, highlighting how exchange policies can directly influence capital allocation options in the mining sector. Against this backdrop, we’ll examine how the...

Encompass Health recently refinanced its debt by securing a new US$1.00 billion revolving credit facility with Truist, extended to March 2031, while also resolving litigation that returned US$43.10 million to the company and Enhabit. Together, the extended credit access and cash recovered from the settlement give Encompass Health more financial flexibility to fund its rehabilitation hospital expansion and operations. Next, we’ll examine how the expanded US$1.00 billion credit facility could...

Why Medpace Holdings (MEDP) Is On Investors’ Radar Today Medpace Holdings (MEDP) is drawing fresh attention after a solid period of operational growth, with annual revenue at US$2.53b and net income of US$451.12m. This is prompting investors to reassess how the stock is currently priced. See our latest analysis for Medpace Holdings. While Medpace’s share price has a 1-day return of 2.34% at US$477.72, the 30-day and 90-day share price returns of 9.92% and 15.62% declines contrast with a...

Uber Technologies (UBER) has moved aggressively into autonomous mobility, striking new robotaxi agreements with Zoox, Nissan, and Wayve while expanding its Women Preferences safety feature nationwide, all against a backdrop of recent share price volatility. See our latest analysis for Uber Technologies. Those robotaxi deals and safety features sit against a mixed trading backdrop, with the share price at US$74.97 and a 3 month share price return of a 12.25% decline, while the 3 year total...

Earlier this month, Humana announced expanded value-based cardiac care partnerships with CVAUSA’s Novocardia, Karoo Health, US Heart and Vascular and Chamber Cardio, giving eligible Medicare Advantage members in multiple states access to enhanced remote monitoring, 24/7 support and coordinated cardiology care. This broadened heart-health program underscores Humana’s emphasis on value-based care for chronic conditions, aiming to improve outcomes while reducing avoidable hospital stays for its...

If you are wondering whether Alphatec Holdings is attractively priced or just looks cheap on the surface, you are in the right place. The share price closed at US$12.66 recently, with returns of 2.6% decline over 7 days, 6.3% decline over 30 days, a 39.0% decline year to date, but a 32.4% gain over the past year and weaker results over 3 and 5 years. These mixed returns have kept Alphatec on the radar as investors reassess how much they are willing to pay for exposure to its spinal surgery...

Cal-Maine Foods (CALM) is back in focus after reports highlighted a sharp contrast between its recent strong revenue and cash flow record and Wall Street expectations for a 36.1% revenue decline over the next year. See our latest analysis for Cal-Maine Foods. At a share price of US$88.18, Cal-Maine has a 30-day share price return of 6.9% and a year to date share price return of 12.37%, while its 5-year total shareholder return of 173.77% points to longer term momentum that contrasts with...

In February 2026, Interface, Inc. expanded its rubber flooring portfolio with noravant™, a first-of-its-kind PVC-free resilient solution that combines high performance, woodgrain design, and a low carbon footprint, initially launched as noravant timber in the Americas and select EMEA markets. The product’s multi-layer construction, industry-first woodgrain rubber aesthetic, and recyclability through Interface’s take-back program highlight how design flexibility and circularity are becoming...

Venture Global, Inc. recently reported past fourth-quarter 2025 sales of US$4.45 billion and net income of US$1.18 billion, announced substantial new LNG offtake agreements with Hanwha Aerospace and Trafigura, and declared a cash dividend of US$0.018 per share payable on March 31 2026. Together, these developments highlight Venture Global’s expanding contracted LNG portfolio, now exceeding 46 MTPA, alongside rising profitability and emerging cash returns to shareholders. We’ll now examine...

Mettler-Toledo International (MTD) has just come through a 7 day losing streak, with the stock shedding about 12% and roughly US$3.4b in market value as institutional sellers stepped back from the sector. See our latest analysis for Mettler-Toledo International. The recent 7 day slide sits on top of a broader cooling trend, with a 30 day share price return of 11.0% and a 90 day share price return of 13.55%, while the 1 year total shareholder return is 1.06% and the 5 year total shareholder...

Why Sharplink Is Drawing Investor Attention Now Sharplink (SBET) has been on many watchlists after a 14.1% gain over the past month, set against a 27.8% decline over the past 3 months that keeps recent volatility front and center. See our latest analysis for Sharplink. Sharplink’s recent bounce, including a 14.1% 30 day share price return, comes after a tougher period and leaves the stock at US$7.59, with a 1 year total shareholder return of 75.4% but a 3 year total shareholder return that...

Nabors Industries (NBR) has drawn investor attention after recent price moves, with the stock closing at US$78.72. Short-term returns remain mixed, while performance over the past month and the previous three months has been stronger. See our latest analysis for Nabors Industries. The recent pullback in Nabors Industries’ share price, with a 1-day share price return decline of 2.62%, comes after stronger momentum, including a 30-day share price return of 11.79% and a 1-year total shareholder...

For investors wondering whether Clearwater Analytics Holdings is attractively priced or still expensive at around US$23.25, this article walks through what the current share price might imply about the company’s underlying value. The stock has seen a 1.2% decline over the last 7 days, a 2.4% decline over 30 days, a 3.6% decline year to date, and a 15.6% decline over 1 year, while the 3 year return sits at 65.5%. This performance can leave investors questioning whether the recent weakness...

If you are wondering whether AppLovin is still good value after a big run in the share price, you are not alone, and this article is going to focus squarely on what the current valuation is telling you. The stock last closed at US$461.45, with returns of a 4.4% decline over 7 days, 0.2% over 30 days, a 25.4% decline year to date, and 69.3% over the past year. This gives a mixed picture for both risk and potential reward. Recent coverage around AppLovin has focused on its position in app...

If you are wondering whether Rithm Capital’s current share price reflects its true worth, you are not alone, especially with income focused financial stocks back on many watchlists. The stock last closed at US$9.87, with returns of 1.1% over 7 days but declines of 7.3% over 30 days, 10.1% year to date, and 5.7% over 1 year. However, the 3 year and 5 year returns of 64.6% and 41.6% show a very different picture for longer term holders. Recent coverage has focused on Rithm Capital’s position...

Green Plains (GPRE) is back on investor radars after director Patrick Sweeney bought 6,383 shares, lifting his stake to 42,719 shares. This purchase coincides with strong positive signals from institutional AI-driven trading strategies. See our latest analysis for Green Plains. That insider purchase comes after a strong run in the share price, with a 90 day share price return of 61.07% and a year to date share price return of 52.92%. The 1 year total shareholder return of 213.46% contrasts...

Sherwin-Williams (SHW) just delivered a fourth quarter in which both earnings per share and revenue came in above analyst expectations, while its Suvinil acquisition sharpened the focus on Latin America expansion and longer term growth potential. See our latest analysis for Sherwin-Williams. Despite the Q4 beat and the Suvinil acquisition signaling a push into Latin America, Sherwin-Williams' recent momentum has cooled. The share price has declined 10.5% over the past month and the 1-year...

Refinancing move reshapes California Resources (CRC) debt profile California Resources (CRC) has drawn fresh attention after announcing plans to issue US$250 million of 7.000% senior unsecured notes due 2034. The company intends to use the proceeds to redeem its existing 8.250% notes due 2029. See our latest analysis for California Resources. The refinancing news comes on top of a strong run in the shares, with a 12.58% 30 day share price return and 35.44% year to date. The 1 year total...